Wells Fargo’s Takeda Pharmaceutical TAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$15.7M Buy
1,013,022
+45,195
+5% +$699K ﹤0.01% 1438
2025
Q1
$14.4M Buy
967,827
+104,149
+12% +$1.55M ﹤0.01% 1420
2024
Q4
$11.4M Sell
863,678
-114,324
-12% -$1.51M ﹤0.01% 1559
2024
Q3
$13.9M Buy
978,002
+106,335
+12% +$1.51M ﹤0.01% 1422
2024
Q2
$11.3M Buy
871,667
+20,722
+2% +$268K ﹤0.01% 1498
2024
Q1
$11.8M Buy
850,945
+76,393
+10% +$1.06M ﹤0.01% 1465
2023
Q4
$11.1M Buy
774,552
+12,756
+2% +$182K ﹤0.01% 1480
2023
Q3
$11.8M Buy
761,796
+2,746
+0.4% +$42.5K ﹤0.01% 1360
2023
Q2
$11.9M Sell
759,050
-135,409
-15% -$2.13M ﹤0.01% 1403
2023
Q1
$14.7M Sell
894,459
-35,763
-4% -$589K ﹤0.01% 1248
2022
Q4
$14.5M Buy
930,222
+47,132
+5% +$735K ﹤0.01% 1251
2022
Q3
$11.5M Buy
883,090
+8,891
+1% +$115K ﹤0.01% 1352
2022
Q2
$12.3M Buy
874,199
+54,466
+7% +$765K ﹤0.01% 1371
2022
Q1
$11.7M Sell
819,733
-956,805
-54% -$13.7M ﹤0.01% 1630
2021
Q4
$24.2M Sell
1,776,538
-448,517
-20% -$6.11M 0.01% 1146
2021
Q3
$36.4M Sell
2,225,055
-43,602
-2% -$714K 0.01% 1227
2021
Q2
$38.2M Sell
2,268,657
-250,614
-10% -$4.22M 0.01% 1217
2021
Q1
$46M Buy
2,519,271
+106,576
+4% +$1.95M 0.01% 1067
2020
Q4
$43.9M Buy
2,412,695
+833,987
+53% +$15.2M 0.01% 1052
2020
Q3
$28.2M Buy
1,578,708
+333,298
+27% +$5.95M 0.01% 1178
2020
Q2
$22.3M Buy
1,245,410
+896,489
+257% +$16.1M 0.01% 1288
2020
Q1
$5.3M Buy
348,921
+79,797
+30% +$1.21M ﹤0.01% 2160
2019
Q4
$5.31M Sell
269,124
-11,559
-4% -$228K ﹤0.01% 2498
2019
Q3
$4.83M Buy
280,683
+99,099
+55% +$1.7M ﹤0.01% 2563
2019
Q2
$3.21M Buy
181,584
+101,140
+126% +$1.79M ﹤0.01% 2926
2019
Q1
$1.64M Buy
80,444
+69,076
+608% +$1.41M ﹤0.01% 3494
2018
Q4
$191K Buy
+11,368
New +$191K ﹤0.01% 4750